Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Journal of the National Cancer Institute|April 19, 1989
Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapyD J ChaplinInternational Journal of Radiation Biology|July 1, 1991
The effect of therapy on tumour vascular functionD J ChaplinBritish Journal of Cancer|November 1, 1986
Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)D J ChaplinRadiation Research|August 1, 1988
Postirradiation modification of tumor blood flow: a method to increase the effectiveness of chemical radiosensitizersD J ChaplinInternational Journal of Radiation Oncology, Biology, Physics|April 1, 1987
The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gainD J Chaplin, B AckerInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Tumor blood flow changes induced by chemical modifiers of radiation responseD J Chaplin, M R HorsmanInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Blood flow modification in the SCCVII tumor: effects of 5-hydroxytryptamine, hydralazine, and propranololC E Peters, D J ChaplinThe British Journal of Cancer. Supplement|July 1, 1996
The influence of oxygen and carbon dioxide tension on the production of TNF alpha by activated macrophagesL E Sampson, D J ChaplinInternational Journal of Radiation Biology|June 1, 1991
Spatial characterization of glutathione depletion in the KHT sarcoma using flow cytometryA I Minchinton, D J ChaplinRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1994
The influence of tumour temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapiesD J Chaplin, M R HorsmanPageof 14